Presentation Resources:
Center for Substance Abuse Treatment. (2007). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. HHS Publication No. (SMA) 04–3939. 2004; Rockville, MD:
http://lib.adai.washington.edu/clearinghouse/downloads/TIP-40-Clinical-Guidelines-for-the-Use-of-Buprenorphine-in-the-Treatment-of-Opioid-Addiction-54.pdf
Center for Substance Abuse Treatment. (2012). Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. HHS Publication No. (SMA) 12–4214. 2005; Rockville, MD:
https://www.ncbi.nlm.nih.gov/books/NBK64164/
Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual (No. RAND/MR-1269-DG-XII/RE). Santa Monica, CA: RAND Corp.; 2001
https://www.rand.org/pubs/monograph_reports/MR1269.html
Allen B J Subst Abuse Treat. 2016 Nov Abstract only
https://pubmed.ncbi.nlm.nih.gov/27692193/
Related Resources:
alliance for pharmacy compounding :
https://a4pc.org/find-a-compounder
Dermatologists’ use of compounding pharmacies and
knowledge of associated regulations
https://drive.google.com/file/d/1MWum30UjT_eOikFyB1BTqFzsUTYswPXl/view?usp=drive_link
Medication-Assisted Treatment (MAT)
https://www.samhsa.gov/medication-assisted-treatment
Buprenorphine
https://library.samhsa.gov/product/facts-about-buprenorphine-treatment-opioid-addiction/sma15-4442
Become a Buprenorphine Waivered Practitioner
https://www.samhsa.gov/medication-assisted-treatment/become-buprenorphine-waivered-practitioner
Special Circumstances for Providing Buprenorphine
https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines/special-circumstances
Methadone
https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/methadone